Alchemab Therapeutics vs Lila Sciences
Which Drug Discovery AI tool is better in 2026?
Alchemab Therapeutics
UK biotech using machine learning to mine patient-derived immune responses for protective
Lila Sciences
Building scientific superintelligence and autonomous AI labs for life, chemical and materials sciences.
Side-by-side
Lila Sciences is the more established option (raised $550M); pricing is comparable on both sides.
| Metric | Alchemab Therapeutics | Lila Sciences |
|---|---|---|
| Taglinei | UK biotech using machine learning to mine patient-derived immune responses for protective | Building scientific superintelligence and autonomous AI labs for life, chemical and materials sciences. |
| Foundedi | — | 2023🏆 |
| HQi | — | Cambridge, US |
| Employeesi | 11-50 | 201-500🏆 |
| Neuron scorei | 42 | 76🏆 |
| Total fundingi | $32M | $550M🏆 |
| Latest roundi | Series A | Series A Extension · Oct 2025 |
| Valuationi | — | $1.3B🏆 |
| Cheapest paid plani | Pricing not disclosed | — |
| Free plani | ✓ | ✗ |
| Free triali | ✓ | ✗ |
| Top tier pricei | Pricing not disclosed | Enterprise Solutions · Contact sales |
| Pricing summaryi | Free | 1 published plans |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Alchemab Therapeutics and Lila Sciences.
| Capability | Alchemab Therapeutics | Lila Sciences |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✓ | ✗ |
| Free trial | ✓ | ✗ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Alchemab Therapeutics
- Offers a free plan
- Offers a free trial
🔵 Strengths of Lila Sciences
- Has raised more capital ($550M vs $32M)
- Higher Neuron score (76 vs 42)
- Newer company (2023)
Which should you choose?
Choose Lila Sciences if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both Drug Discovery tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Lila Sciences if you want the most established option — it has raised $550M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Alchemab Therapeutics vs Lila Sciences — which is better?
It depends on your priority. Alchemab Therapeutics is the leaner option; Lila Sciences has broader feature depth. See the side-by-side table above.
Is Alchemab Therapeutics cheaper than Lila Sciences?
No — Lila Sciences's cheapest paid plan is Enterprise · Contact sales, while Alchemab Therapeutics's is Free.
Do Alchemab Therapeutics and Lila Sciences offer free plans?
Alchemab Therapeutics: Yes, has a free plan. Lila Sciences: Paid only.
Explore more Drug Discovery tools
Contextual paths to related AI startups, deals and rankings.